相关实验视频
Updated: Jun 14, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.4K
多发性硬化症和肝脑脑退化症患者的心理治疗特征
I Voloshyn-Gaponov1, I Lantukh2, N Mikhanovska3
11Kharkiv Institute of Interregional Academy of Personnel Management; 2Institute of Neurology, Psychiatry, and Narcology under the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine.
Georgian medical news
|September 4, 2024
概括
认知障碍在多发性硬化和威尔逊病中很常见,特别是在老年患者和肝脑退行症患者中. 早期的个性化治疗对于预防痴呆症进展至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 遗传学 是一个遗传学.
背景情况:
- 在生理上,衰老会影响诸如记忆和学习之类的认知功能.
- 痴呆症由各种因素引起,包括退行性,血管性和有毒性原因.
- 多发性硬化症 (MS) 和威尔逊病 (WD) 是影响认知健康的重要神经疾病.
研究的目的:
- 对MS和WD患者进行全面的临床和实验室检查.
- 调查MS和WD中神经退行过程的流行和性质.
- 探索预防这些患者群体认知衰退的潜在策略.
主要方法:
- 使用迷你精神状态检查选认知功能.
- 通过测试语言记忆来评估语言记忆.
- 记住10个单词的记忆力
- 方法. 方法. 方法.
- 用Derogatis SCl-90-P.P.评估个性和情绪状态
- 精神诊断检查了111名多发性硬化症患者和33名脑筋疲劳症患者.
主要成果:
- 认知障碍影响了44.9%的年轻MS患者和91.2%的老年MS患者.
- 在69.1%的MS患者中观察到口头记忆障碍.
- 超过一半的WD患者 (66.7%) 表现出认知功能的生产力受损,78.8%显示出各种精神功能障碍.
结论:
- 参与认知功能的大脑结构在MS和肝脑退化中总是受到影响,导致缺陷.
- 对于管理这些患者来说,全面的,病原遗传学上合理的,个性化的治疗是必不可少的.
- 开发缓解疗法以防止认知障碍进展为痴呆症是未来研究的关键方向.
相关概念视频
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
Psychosis: Goals of Pharmacotherapy
113
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
113
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
520
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
520
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454

